Search Results 581-590 of 24092 for prostate cancer
A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer · Overview · Participation eligibility.
Genomic attributes of prostate cancer across primary and metastatic ... Prostate Cancer Prostatic Dis. 2025 Jun; 28 (2):506-508 Epub 2024 Feb 27
Michael Tessmer discovered he had prostate cancer early enough to lead to successful treatment. Michael Tessmer got out of his parents' car and stared at the ...
... prostate cancer (mCRPC) who have previously been treated with one, and only one, NHT for their prostate cancer disease. Participation eligibility.
... Prostate Cancer. Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer ...
After John Sullivan experienced the benefits of a Choline C-11 PET scan when he had a recurrence of prostate cancer, he and his fiancée, Sheri Butler, were ...
Prostatectomy (prostate removal surgery) · PSMA PET scan for prostate cancer · Radiation therapy for prostate cancer · Radiofrequency ablation for cancer ...
... cancers. His work is supported by the National Cancer Institute and Prostate Cancer Foundation. Focus areas. Immunotherapy resistance mechanisms. Immune ...
Prostate cancer screening: Should you get a PSA test? Find out about pros and cons of the prostate-specific antigen (PSA) test. Highlights Headaches and ...
Kase has developed expertise in treating patients with prostate cancer, kidney cancer, bladder cancer, and testicular cancer. He is engaged in clinical ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.